Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026)

Zai Lab (ZLAB) posted Change in Accured Expenses of -$17.6 million for Q1 2026, down 253.12% sequentially from $11.5 million in Q4 2025, and up 24.22% YoY from -$14.2 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Zai Lab has reported Change in Accured Expenses for 7 years, with the latest figure at -$17.6 million in Q1 2026.

  • Quarterly Change in Accured Expenses rose 24.22% year-over-year to -$17.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 193.64% YoY) and the FY2025 annual result came in at $4.8 million, up 121.57% from the prior year.
  • Change in Accured Expenses slipped to -$17.6 million in Q1 2026 per ZLAB's latest filing, from $11.5 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $19.6 million in Q4 2023 and troughed at -$34.2 million in Q1 2024.
  • A 5-year average of -$453411.8 and a median of $5.7 million in 2022 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses tumbled 140.71% in 2022, then surged 836.09% in 2025.
  • Over 5 years, Change in Accured Expenses stood at $5.8 million in 2022, then jumped by 239.75% to $19.6 million in 2023, then declined by 24.26% to $14.8 million in 2024, then dropped by 22.34% to $11.5 million in 2025, then slumped by 253.12% to -$17.6 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$17.6 million, $11.5 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn 1.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.24 Mn
Mar 31, 2026 -17.64 Mn
Dec 31, 2025 11.52 Mn
Sep 30, 2025 9.18 Mn
Jun 30, 2025 7.33 Mn
Mar 31, 2025 -23.28 Mn
Dec 31, 2024 14.83 Mn
Sep 30, 2024 -1.25 Mn
Jun 30, 2024 -1.40 Mn
Mar 31, 2024 -34.20 Mn
Dec 31, 2023 19.58 Mn
Sep 30, 2023 6.99 Mn
Jun 30, 2023 8.83 Mn
Mar 31, 2023 -15.59 Mn
Dec 31, 2022 5.76 Mn
Sep 30, 2022 4.73 Mn
Jun 30, 2022 5.74 Mn
Mar 31, 2022 -8.84 Mn
Dec 31, 2021 9.55 Mn
Sep 30, 2021 -7.49 Mn